-+ 0.00%
-+ 0.00%
-+ 0.00%

GUARDANT HEALTH ANNOUNCES APPROVAL IN EUROPE OF GUARDANT360® CDX AS COMPANION DIAGNOSTIC FOR ASTRAZENECA’S ETCAMAH™ (CAMIZESTRANT) IN ADVANCED ER-POSITIVE BREAST CANCER

Reuters·10/08/2026 20:12:00

Please log in to view news